Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.
Market Analysis and Insights: Global Immuno-Cell Therapy Market
The global Immuno-Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immuno-Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immuno-Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immuno-Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immuno-Cell Therapy market.
Immuno-Cell Therapy Breakdown Data by Type
Passive Immune (NK, LAK etc)
Active Immune
Immuno-Cell Therapy Breakdown Data by Application
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Based on regional and country-level analysis, the Immuno-Cell Therapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Immuno-Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Market Analysis and Insights: Global Immuno-Cell Therapy Market
The global Immuno-Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immuno-Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immuno-Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immuno-Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immuno-Cell Therapy market.
Immuno-Cell Therapy Breakdown Data by Type
Passive Immune (NK, LAK etc)
Active Immune
Immuno-Cell Therapy Breakdown Data by Application
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Based on regional and country-level analysis, the Immuno-Cell Therapy market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Immuno-Cell Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Passive Immune (NK, LAK etc)
1.2.3 Active Immune
1.3 Market by Application
1.3.1 Global Immuno-Cell Therapy Market Share by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Cardiovascular Disease (CVD)
1.3.4 Orthopedic
1.3.5 Wound Healing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Cell Therapy Market Perspective (2015-2026)
2.2 Global Immuno-Cell Therapy Growth Trends by Regions
2.2.1 Immuno-Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immuno-Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Immuno-Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Cell Therapy Players by Market Size
3.1.1 Global Top Immuno-Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Immuno-Cell Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immuno-Cell Therapy Revenue
3.4 Global Immuno-Cell Therapy Market Concentration Ratio
3.4.1 Global Immuno-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Cell Therapy Revenue in 2019
3.5 Key Players Immuno-Cell Therapy Area Served
3.6 Key Players Immuno-Cell Therapy Product Solution and Service
3.7 Date of Enter into Immuno-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Cell Therapy Breakdown Data by Type (2015-2026)
4.1 Global Immuno-Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Immuno-Cell Therapy Forecasted Market Size by Type (2021-2026)
5 Immuno-Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global Immuno-Cell Therapy Historic Market Size by Application (2015-2020)
5.2 Global Immuno-Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Immuno-Cell Therapy Market Size (2015-2026)
6.2 North America Immuno-Cell Therapy Market Size by Type (2015-2020)
6.3 North America Immuno-Cell Therapy Market Size by Application (2015-2020)
6.4 North America Immuno-Cell Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Immuno-Cell Therapy Market Size (2015-2026)
7.2 Europe Immuno-Cell Therapy Market Size by Type (2015-2020)
7.3 Europe Immuno-Cell Therapy Market Size by Application (2015-2020)
7.4 Europe Immuno-Cell Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Immuno-Cell Therapy Market Size (2015-2026)
8.2 China Immuno-Cell Therapy Market Size by Type (2015-2020)
8.3 China Immuno-Cell Therapy Market Size by Application (2015-2020)
8.4 China Immuno-Cell Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Immuno-Cell Therapy Market Size (2015-2026)
9.2 Japan Immuno-Cell Therapy Market Size by Type (2015-2020)
9.3 Japan Immuno-Cell Therapy Market Size by Application (2015-2020)
9.4 Japan Immuno-Cell Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Immuno-Cell Therapy Market Size (2015-2026)
10.2 Southeast Asia Immuno-Cell Therapy Market Size by Type (2015-2020)
10.3 Southeast Asia Immuno-Cell Therapy Market Size by Application (2015-2020)
10.4 Southeast Asia Immuno-Cell Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 MEDINET Co
11.1.1 MEDINET Co Company Details
11.1.2 MEDINET Co Business Overview
11.1.3 MEDINET Co Immuno-Cell Therapy Introduction
11.1.4 MEDINET Co Revenue in Immuno-Cell Therapy Business (2015-2020))
11.1.5 MEDINET Co Recent Development
11.2 Erytech
11.2.1 Erytech Company Details
11.2.2 Erytech Business Overview
11.2.3 Erytech Immuno-Cell Therapy Introduction
11.2.4 Erytech Revenue in Immuno-Cell Therapy Business (2015-2020)
11.2.5 Erytech Recent Development
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Details
11.3.2 Seta Clinic Group Business Overview
11.3.3 Seta Clinic Group Immuno-Cell Therapy Introduction
11.3.4 Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2015-2020)
11.3.5 Seta Clinic Group Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Immuno-Cell Therapy Introduction
11.4.4 Takeda Revenue in Immuno-Cell Therapy Business (2015-2020)
11.4.5 Takeda Recent Development
11.5 SBI Holdings
11.5.1 SBI Holdings Company Details
11.5.2 SBI Holdings Business Overview
11.5.3 SBI Holdings Immuno-Cell Therapy Introduction
11.5.4 SBI Holdings Revenue in Immuno-Cell Therapy Business (2015-2020)
11.5.5 SBI Holdings Recent Development
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Details
11.6.2 Oxford BioTherapeutics Business Overview
11.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Introduction
11.6.4 Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2015-2020)
11.6.5 Oxford BioTherapeutics Recent Development
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Details
11.7.2 Fate Therapeutics Business Overview
11.7.3 Fate Therapeutics Immuno-Cell Therapy Introduction
11.7.4 Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2015-2020)
11.7.5 Fate Therapeutics Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Immuno-Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Immuno-Cell Therapy Business (2015-2020)
11.8.5 Gilead Sciences Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Cell Therapy Introduction
11.9.4 Novartis Revenue in Immuno-Cell Therapy Business (2015-2020)
11.9.5 Novartis Recent Development
11.10 Osiris
11.10.1 Osiris Company Details
11.10.2 Osiris Business Overview
11.10.3 Osiris Immuno-Cell Therapy Introduction
11.10.4 Osiris Revenue in Immuno-Cell Therapy Business (2015-2020)
11.10.5 Osiris Recent Development
11.11 Vericel Corporation
10.11.1 Vericel Corporation Company Details
10.11.2 Vericel Corporation Business Overview
10.11.3 Vericel Corporation Immuno-Cell Therapy Introduction
10.11.4 Vericel Corporation Revenue in Immuno-Cell Therapy Business (2015-2020)
10.11.5 Vericel Corporation Recent Development
11.12 Fujifilm Cellular Dynamics
10.12.1 Fujifilm Cellular Dynamics Company Details
10.12.2 Fujifilm Cellular Dynamics Business Overview
10.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Introduction
10.12.4 Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2015-2020)
10.12.5 Fujifilm Cellular Dynamics Recent Development
11.13 JCR Pharmaceuticals
10.13.1 JCR Pharmaceuticals Company Details
10.13.2 JCR Pharmaceuticals Business Overview
10.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Introduction
10.13.4 JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2015-2020)
10.13.5 JCR Pharmaceuticals Recent Development
11.14 Beike Biotechnology
10.14.1 Beike Biotechnology Company Details
10.14.2 Beike Biotechnology Business Overview
10.14.3 Beike Biotechnology Immuno-Cell Therapy Introduction
10.14.4 Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2015-2020)
10.14.5 Beike Biotechnology Recent Development
11.15 Golden Meditech
10.15.1 Golden Meditech Company Details
10.15.2 Golden Meditech Business Overview
10.15.3 Golden Meditech Immuno-Cell Therapy Introduction
10.15.4 Golden Meditech Revenue in Immuno-Cell Therapy Business (2015-2020)
10.15.5 Golden Meditech Recent Development
11.16 Guanhao Biotech
10.16.1 Guanhao Biotech Company Details
10.16.2 Guanhao Biotech Business Overview
10.16.3 Guanhao Biotech Immuno-Cell Therapy Introduction
10.16.4 Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2015-2020)
10.16.5 Guanhao Biotech Recent Development
11.17 Beroni Group
10.17.1 Beroni Group Company Details
10.17.2 Beroni Group Business Overview
10.17.3 Beroni Group Immuno-Cell Therapy Introduction
10.17.4 Beroni Group Revenue in Immuno-Cell Therapy Business (2015-2020)
10.17.5 Beroni Group Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Passive Immune (NK, LAK etc)
1.2.3 Active Immune
1.3 Market by Application
1.3.1 Global Immuno-Cell Therapy Market Share by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Cardiovascular Disease (CVD)
1.3.4 Orthopedic
1.3.5 Wound Healing
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Cell Therapy Market Perspective (2015-2026)
2.2 Global Immuno-Cell Therapy Growth Trends by Regions
2.2.1 Immuno-Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immuno-Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Immuno-Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Cell Therapy Players by Market Size
3.1.1 Global Top Immuno-Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Immuno-Cell Therapy Revenue Market Share by Players (2015-2020)
3.2 Global Immuno-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immuno-Cell Therapy Revenue
3.4 Global Immuno-Cell Therapy Market Concentration Ratio
3.4.1 Global Immuno-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Cell Therapy Revenue in 2019
3.5 Key Players Immuno-Cell Therapy Area Served
3.6 Key Players Immuno-Cell Therapy Product Solution and Service
3.7 Date of Enter into Immuno-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Cell Therapy Breakdown Data by Type (2015-2026)
4.1 Global Immuno-Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Immuno-Cell Therapy Forecasted Market Size by Type (2021-2026)
5 Immuno-Cell Therapy Breakdown Data by Application (2015-2026)
5.1 Global Immuno-Cell Therapy Historic Market Size by Application (2015-2020)
5.2 Global Immuno-Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Immuno-Cell Therapy Market Size (2015-2026)
6.2 North America Immuno-Cell Therapy Market Size by Type (2015-2020)
6.3 North America Immuno-Cell Therapy Market Size by Application (2015-2020)
6.4 North America Immuno-Cell Therapy Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Immuno-Cell Therapy Market Size (2015-2026)
7.2 Europe Immuno-Cell Therapy Market Size by Type (2015-2020)
7.3 Europe Immuno-Cell Therapy Market Size by Application (2015-2020)
7.4 Europe Immuno-Cell Therapy Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Immuno-Cell Therapy Market Size (2015-2026)
8.2 China Immuno-Cell Therapy Market Size by Type (2015-2020)
8.3 China Immuno-Cell Therapy Market Size by Application (2015-2020)
8.4 China Immuno-Cell Therapy Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Immuno-Cell Therapy Market Size (2015-2026)
9.2 Japan Immuno-Cell Therapy Market Size by Type (2015-2020)
9.3 Japan Immuno-Cell Therapy Market Size by Application (2015-2020)
9.4 Japan Immuno-Cell Therapy Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Immuno-Cell Therapy Market Size (2015-2026)
10.2 Southeast Asia Immuno-Cell Therapy Market Size by Type (2015-2020)
10.3 Southeast Asia Immuno-Cell Therapy Market Size by Application (2015-2020)
10.4 Southeast Asia Immuno-Cell Therapy Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 MEDINET Co
11.1.1 MEDINET Co Company Details
11.1.2 MEDINET Co Business Overview
11.1.3 MEDINET Co Immuno-Cell Therapy Introduction
11.1.4 MEDINET Co Revenue in Immuno-Cell Therapy Business (2015-2020))
11.1.5 MEDINET Co Recent Development
11.2 Erytech
11.2.1 Erytech Company Details
11.2.2 Erytech Business Overview
11.2.3 Erytech Immuno-Cell Therapy Introduction
11.2.4 Erytech Revenue in Immuno-Cell Therapy Business (2015-2020)
11.2.5 Erytech Recent Development
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Details
11.3.2 Seta Clinic Group Business Overview
11.3.3 Seta Clinic Group Immuno-Cell Therapy Introduction
11.3.4 Seta Clinic Group Revenue in Immuno-Cell Therapy Business (2015-2020)
11.3.5 Seta Clinic Group Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Immuno-Cell Therapy Introduction
11.4.4 Takeda Revenue in Immuno-Cell Therapy Business (2015-2020)
11.4.5 Takeda Recent Development
11.5 SBI Holdings
11.5.1 SBI Holdings Company Details
11.5.2 SBI Holdings Business Overview
11.5.3 SBI Holdings Immuno-Cell Therapy Introduction
11.5.4 SBI Holdings Revenue in Immuno-Cell Therapy Business (2015-2020)
11.5.5 SBI Holdings Recent Development
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Details
11.6.2 Oxford BioTherapeutics Business Overview
11.6.3 Oxford BioTherapeutics Immuno-Cell Therapy Introduction
11.6.4 Oxford BioTherapeutics Revenue in Immuno-Cell Therapy Business (2015-2020)
11.6.5 Oxford BioTherapeutics Recent Development
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Details
11.7.2 Fate Therapeutics Business Overview
11.7.3 Fate Therapeutics Immuno-Cell Therapy Introduction
11.7.4 Fate Therapeutics Revenue in Immuno-Cell Therapy Business (2015-2020)
11.7.5 Fate Therapeutics Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Immuno-Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Immuno-Cell Therapy Business (2015-2020)
11.8.5 Gilead Sciences Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Cell Therapy Introduction
11.9.4 Novartis Revenue in Immuno-Cell Therapy Business (2015-2020)
11.9.5 Novartis Recent Development
11.10 Osiris
11.10.1 Osiris Company Details
11.10.2 Osiris Business Overview
11.10.3 Osiris Immuno-Cell Therapy Introduction
11.10.4 Osiris Revenue in Immuno-Cell Therapy Business (2015-2020)
11.10.5 Osiris Recent Development
11.11 Vericel Corporation
10.11.1 Vericel Corporation Company Details
10.11.2 Vericel Corporation Business Overview
10.11.3 Vericel Corporation Immuno-Cell Therapy Introduction
10.11.4 Vericel Corporation Revenue in Immuno-Cell Therapy Business (2015-2020)
10.11.5 Vericel Corporation Recent Development
11.12 Fujifilm Cellular Dynamics
10.12.1 Fujifilm Cellular Dynamics Company Details
10.12.2 Fujifilm Cellular Dynamics Business Overview
10.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Introduction
10.12.4 Fujifilm Cellular Dynamics Revenue in Immuno-Cell Therapy Business (2015-2020)
10.12.5 Fujifilm Cellular Dynamics Recent Development
11.13 JCR Pharmaceuticals
10.13.1 JCR Pharmaceuticals Company Details
10.13.2 JCR Pharmaceuticals Business Overview
10.13.3 JCR Pharmaceuticals Immuno-Cell Therapy Introduction
10.13.4 JCR Pharmaceuticals Revenue in Immuno-Cell Therapy Business (2015-2020)
10.13.5 JCR Pharmaceuticals Recent Development
11.14 Beike Biotechnology
10.14.1 Beike Biotechnology Company Details
10.14.2 Beike Biotechnology Business Overview
10.14.3 Beike Biotechnology Immuno-Cell Therapy Introduction
10.14.4 Beike Biotechnology Revenue in Immuno-Cell Therapy Business (2015-2020)
10.14.5 Beike Biotechnology Recent Development
11.15 Golden Meditech
10.15.1 Golden Meditech Company Details
10.15.2 Golden Meditech Business Overview
10.15.3 Golden Meditech Immuno-Cell Therapy Introduction
10.15.4 Golden Meditech Revenue in Immuno-Cell Therapy Business (2015-2020)
10.15.5 Golden Meditech Recent Development
11.16 Guanhao Biotech
10.16.1 Guanhao Biotech Company Details
10.16.2 Guanhao Biotech Business Overview
10.16.3 Guanhao Biotech Immuno-Cell Therapy Introduction
10.16.4 Guanhao Biotech Revenue in Immuno-Cell Therapy Business (2015-2020)
10.16.5 Guanhao Biotech Recent Development
11.17 Beroni Group
10.17.1 Beroni Group Company Details
10.17.2 Beroni Group Business Overview
10.17.3 Beroni Group Immuno-Cell Therapy Introduction
10.17.4 Beroni Group Revenue in Immuno-Cell Therapy Business (2015-2020)
10.17.5 Beroni Group Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
